Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dihydrotestosterone measured in core biopsies from prostatic tissues.

E Bruun1, H Frandsen, K Nielsen

  • 1Department of Urology, Gentofte Hospital, University of Copenhagen, Denmark.

American Journal of Clinical Oncology
|January 1, 1988
PubMed
Summary

Dihydrotestosterone (DHT) levels, when related to DNA, were lower in prostate cancer tissue. This finding, along with nuclear volume analysis, aids in monitoring disease progression and treatment response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Value of Phrenic-Exairesis in the Treatment of Pulmonary Tuberculosis.

The Indian medical gazette·2017
Same author

A New and Simple Treatment for Intestinal Tuberculosis, Introduced by M. McConkey.

The Indian medical gazette·2017
Same author

An Investigation of After-Histories of Sanatorium Patients in India.

The Indian medical gazette·2017
Same author

An Indian Journal of Tuberculosis.

The Indian medical gazette·2017
Same author

The Application of Our Knowledge of Tuberculosis to Indian Conditions.

The Indian medical gazette·2017
Same author

The Sanocrysin Treatment of Tuberculosis with Special Reference to Indian Patients.

The Indian medical gazette·2017

Area of Science:

  • Endocrinology
  • Oncology
  • Urology

Background:

  • Prostatic cancer management often involves endocrine manipulation.
  • Understanding dihydrotestosterone (DHT) variations in prostatic tissue is crucial for treatment efficacy.
  • Accurate measurement of DHT levels can inform therapeutic strategies.

Purpose of the Study:

  • To measure dihydrotestosterone (DHT) levels in prostatic tissue relative to DNA content.
  • To investigate DHT variations in relation to endocrine manipulations in metastatic prostate cancer.
  • To assess the utility of DHT/DNA ratio and nuclear volume in differentiating prostate cancer from benign hyperplasia.

Main Methods:

  • Tissue samples (10-15 mg) were obtained via punch biopsy from the prostate gland.
  • Dihydrotestosterone (DHT) was assayed using a modified commercial testosterone/dihydrotestosterone kit.

Related Experiment Videos

  • DHT levels were correlated with DNA content and weighted mean nuclear volume.

    • Main Results:

    • A significantly lower DHT/DNA ratio was observed in prostatic cancer tissue compared to benign hyperplasia.
    • Prostate cancer specimens exhibited a higher mean nuclear volume and greater nuclear variation than hyperplasia.
    • Neither DHT/DNA ratio nor mean nuclear volume alone was sufficient for individual patient management.

    Conclusions:

    • The DHT/DNA ratio and mean nuclear volume can provide valuable insights into prostate cancer characteristics.
    • These measurements can aid in monitoring disease progression and response to endocrine therapy.
    • Repeated measurements of DHT/DNA ratio and nuclear volume support clinical decision-making in prostate cancer treatment.